Results 101 to 110 of about 14,212 (288)
Artificial Organs, EarlyView.TESCS‐ABT induced neurophysiological changes in individuals with chronic complete SCI, however these did not consistently translate into functional improvements. These findings highlight the role of residual supraspinal connectivity and inform future research to optimise this neurotechnology for SCI rehabilitation and identify likely responders ...
E. L. McNicol +6 more
wiley +1 more source
Cloning and Whole Nucleotide Sequence of the Gene for the Light Chain Component of Botulinum Type E Toxin from Clostridium butyricum Strain BL6340 and Clostridium botulinum Type E Strain Mashike [PDF]
, 1992 Nobuhiro Fujii +7 more
openalex +1 more source
BJU International, EarlyView.Objectives To investigate the associations between how reusable flexible cystoscopes (FCs) are managed during their functioning lifetime and their longevity. Patients and Methods This was an exploratory retrospective analysis of administrative data collected by a medical supplies company (KARL STORZ Endoscopy (UK) Ltd) on FC usage linked at a National ...
Joseph B. John +5 more
wiley +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
British Journal of Pharmacology, EarlyView.Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Effects of Botulinum Toxin Type A on the Axial Skin Flap Survival [PDF]
, 2022 Maryam Iranpour +4 more
openalex +1 more source
[Botulinum toxin Type A. Indications and results].
Revista de neurologia, 2003 Since introduction for clinical in the 80s, the botulinum toxin type A is being used with effectiveness in the treatment of different disorders that goes with exaggerated muscular activity. Numerous studies have been demonstrated useful for focal treatment of spasticity.Some indications of the botulinum toxin type A for the treatment of the cerebral ...
Póo P +5 more
openaire +3 more sources
Developmental Medicine &Child Neurology, EarlyView.In this study, we followed a group of children 2 to 6 years old with spastic cerebral palsy functioning in GMFCS levels I–III, over 3 years. Sixty‐five received BoNT‐A and 59 did not. Repeated BoNT‐A injections over 3 years were not associated with improvements in gross motor function or passive ankle dorsiflexion. Daily step counts, favouring the BoNT‐
Darcy Fehlings +11 more
wiley +1 more source
The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta‐analysis of randomized controlled trials [PDF]
, 2019 Jiangshan Wei +8 more
openalex +1 more source
Equine Veterinary Education, EarlyView.Summary An uncommon complication following prosthetic laryngoplasty was reported in a 4‐year‐old Andalusian mare. The mare was presented with a previously diagnosed left‐sided recurrent laryngeal neuropathy, after initial evaluation the mare underwent ventriculocordectomy and prosthetic laryngoplasty.
J. L. Sanclemente +2 more
wiley +1 more source